iOS app Android app


CVS Boosts Access To EpiPen Rival That's Only 17 Percent The Cost

The Huffington Post | Anna Almendrala | Posted 01.13.2017 | Healthy Living

Families who rely on an epinephrine auto-injector to prevent life-threatening allergic reactions now have a more cost-effective option. CVS, the natio...

Many Doctors Are As Confused As You Are About Food Allergies

The Huffington Post | Allison Fox | Posted 12.06.2016 | Healthy Living

Food allergies are a serious matter that typically require a physician’s diagnosis. But a new report is now pointing to some confusion ― among bot...

The Talking Auto-Injector Set To Make A Comeback -- But Is It Safe?

Lianne Mandelbaum | Posted 11.18.2016 | Parents
Lianne Mandelbaum

It was an ordinary morning, I had just opened my computer when a new email flitting by on the top right of my screen caught my eye - the subject line ...

Even The Military Is Sick Of EpiPen's Price Hikes

Reuters | Anna Almendrala | Posted 10.28.2016 | Healthy Living

By Caroline Humer and Ruthy Munoz NEW YORK/WASHINGTON, Oct 28 (Reuters) - Mylan NV’s price hikes on EpiPens have added millions to U.S. Department o...

How a Beleaguered Industry Needs to Adapt - and Why it Doesn't Have a Choice

Peter Miller | Posted 10.12.2016 | Business
Peter Miller

The pharmaceutical industry has had a rough go of it lately. Between negative headlines (with the recent Mylan EpiPen controversy only the latest controversy), congressional inquiries and calls from insurers and the medical community to defend the price of medications, today's value-focused healthcare landscape presents an unprecedented set of challenges for the sector.

EpiPen Moms Speak Out For CA Prop 61 And Against Drug Company Price Gouging

Jamie Court | Posted 10.11.2016 | Los Angeles
Jamie Court

Drug companies, who are spending $90 million to stop Proposition 61, will continue to overcharge Californians until we pass Prop 61 to stop their price gouging.

EpiPen Maker To Pay $465 Million For Shifty Medicaid Billing Practices

Reuters | Ryan Grenoble | Posted 10.09.2016 | Business

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treat...

One Company Takes A Stand

Paul Alexander | Posted 10.07.2016 | Politics
Paul Alexander

These days, consumers must deal with the rising cost of prescription drugs, but over the past year some price hikes have been so astronomical they mad...

The Broader Lessons Of The EpiPen Debacle

James R. Baker, Jr. M.D. | Posted 09.28.2016 | Business
James R. Baker, Jr. M.D.

The current discussion around the EpiPen appropriately focuses on the acute need to help patients with access to EAIs. However, we believe the U.S. needs to urgently address the market forces that have led to this problem.

Don't Shoot The Messenger: An Allergist's Perspective On The EpiPen Price Hike

Julie Kuriakose, M.D. | Posted 09.27.2016 | Healthy Living
Julie Kuriakose, M.D.

EpiPen has become the industry standard and in most cases the only option, and a price surge for this product certainly warrants this current uproar.

Mylan's EpiPen: Poster Child For Corporate Greed

John Geyman | Posted 09.27.2016 | Politics
John Geyman

The soaring cost of EpiPens is the latest in a long run of wildly increased costs of prescription drugs that are unaffordable to many, such as Turing's Daraprim for toxoplasmosis (5,000 percent overnight price increase) and Gilead's Sovaldi for hepatitis C ($84,000 for a 12-week treatment).

EpiPens and Congress: It's Time to Fix the Real Problem

Caroline Moassessi | Posted 09.28.2016 | Politics
Caroline Moassessi

I have my watch set to see when the real work is going to start. Now that we not only have the nation’s attention, Congress is finally listening. Th...

Can We Get Rid Of EpiPen Price Gouges With Science? An Interview With Ajan Reginald

Megan Brame-Finkelstein | Posted 09.22.2016 | Science
Megan Brame-Finkelstein

Lately this nonsense with price gouging made me wonder if there were alternatives. What if we could somehow cut out the middleman of pharmaceutical companies and instead look to something else for a solution?

Members Of Congress Rip Into Mylan CEO

The Huffington Post | LaurenWeber | Posted 09.23.2016 | Politics

In a blistering hearing on Wednesday, members of Congress went after Mylan CEO Heather Bresch amid uproar over the soaring price of EpiPens. Rep. Jaso...

Food Allergy Voices Are Called Upon To Congress Re: EpiPen

Caroline Moassessi | Posted 09.19.2016 | Politics
Caroline Moassessi

So where do we start to fix this broken pharma system? Headlines are screaming about the public outrage over high EpiPen prices while Congress awakens...

The Long, Strange History of the EpiPen

Healthline | Posted 09.16.2016 | Healthy Living

Anyone following the recent pricing controversy over the EpiPen might be surprised to learn that its inventor never collected a penny in royalties. S...

Innovation and Regulation in Pharmaceuticals

Adam Grossman | Posted 09.15.2016 | Impact
Adam Grossman

I am a caregiver and patient advocate for my mom. I am also a proud co-founder of Give to Cure. My dynamic and awesome co- founder, Lou Reese, is a pa...

EpiPen Prices Sting, But Who Should Carry One?

Craig Bowron | Posted 09.14.2016 | Healthy Living
Craig Bowron

The EpiPen, a pre-filled automated syringe used to treat serious allergic reactions, is the latest example of what happens when the business of medici...

New EpiPen Competitor Could Be Approved In 2017

Reuters | Anna Almendrala | Posted 09.12.2016 | Healthy Living

By Ransdell Pierson and Deena Beasley (Reuters) - Teva Pharmaceutical Industries Ltd said Friday it aims to win U.S. approval by late 2017 or early 2...

EpiPen Price Gouging Affects Us All

Debra B. Whitman, Ph.D. | Posted 09.08.2016 | Healthy Living
Debra B. Whitman, Ph.D.

Skyrocketing prescription drug prices could translate into higher premiums, deductibles, even higher taxes as Medicare, Medicaid struggle to pay bills...

Protecting People With Life Threatening Allergies: Remembering Senator Debbie Smith

Caroline Moassessi | Posted 09.09.2016 | Politics
Caroline Moassessi

As she kicked off her shoes and curled up in the large cushioned chair in the hotel lobby, Democrat Senator Debbie Smith asked me tell her everything ...

Greed and Drugs, Sex and Rock 'n' Roll.

Pam Ferderbar | Posted 09.02.2016 | Comedy
Pam Ferderbar

Seriously. I am getting so old (or the news is getting so bad) that the mere act of reading the newspaper causes me to hear my blood pressure. Literally. The other day I was reading about EpiPen and it sounded like the Quicksilver Big Wave Invitational in my head.

Hillary Clinton Announces Plan To Address 'Unjustified' Price Hikes On Life-Saving Drugs

Reuters | Paige Lavender | Posted 09.02.2016 | Politics

WASHINGTON/NEW YORK (Reuters) - Hillary Clinton said on Friday that if elected to the White House she would create an oversight panel to protect U.S. ...

Mylan Is Proof That Big Business Picks America's Pockets While Gov't Mostly Looks Away

Michael Winship | Posted 08.31.2016 | Politics
Michael Winship

Cash and carry has become nothing more than standard operating procedure in politics and government, and it's wrecking the republic. The whole system is rotten to the core, corrupted by big business and special interests from the seventh son to the seventh son.

EpiPen Alternatives Exist, And They May Be Cheaper

Live Science | Erin Schumaker | Posted 08.30.2016 | Healthy Living

The soaring price of the EpiPen has garnered controversy recently, but there are alternatives to this well-known allergy treatment device. The EpiPen ...